Abstract P4-02-07: Early Optical Tomography Changes Predict Breast Cancer Response to Neoadjuvant Chemotherapy
EA Lim(Columbia University Irving Medical Center), DL Hershman(Columbia University Irving Medical Center), Bret Taback(Columbia College), Kevin Kalinsky(Emory University), Matthew J. Maurer(Mayo Clinic in Arizona), Susan Refice(Columbia College), Andreas H. Hielscher(New York University), JE Gunther(Columbia University Irving Medical Center), Molly Flexman(Philips (United States)), Hanina Hibshoosh, Mindy A. Brown(Columbia University), Hyung‐Kwan Kim(Seoul National University), Sheldon Feldman(Presbyterian Hospital), KD Crew(Columbia University Irving Medical Center), M Alvarez-Cid(Columbia University Irving Medical Center)
Cited by 0
Related Papers
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846
A molecular single-cell lung atlas of lethal COVID-19
|Nature|2021|735